Employer profile
Endo Pharmaceuticals
2 certified H-1B filings across 2 fiscal years.
FY2021 filings
1
FY2021 median
$273k
Top role
It Audit Manager
1 filings
Top state
NY
1 filings
Endo Pharmaceuticals has filed 2 certified H-1B Labor Condition Applications over FY2020–FY2021. In FY2021, its median certified base salary was $273k ($273k–$273k interquartile range). The most-filed role is It Audit Manager (1 filings).
Year-over-year
How Endo Pharmaceuticals hired across H-1B fiscal years. YoY column compares to the prior FY.
| FY | Filings | Median $ | YoY % |
|---|---|---|---|
| FY2021 | 1 | $273k | 0 |
| FY2020 | 1 | $137k | — |
Top job titles
Most-filed positions, across all years (raw DOL titles).
| Job Title | Filings | Median |
|---|---|---|
| It Audit Manager | 1 | $137k |
Top worksite states
Where this employer files.
| State | Filings | Median |
|---|---|---|
| NY | 1 | $273k |
| PA | 1 | $137k |
Prevailing wage level distribution
DOL Levels I–IV approximate experience tiers (I = entry, IV = fully competent). A heavy Level I/II skew suggests entry-level / contractor-style hiring; a heavy IV skew suggests senior in-house roles.
Lvl III
150%
Lvl IV
150%
Frequently asked questions
- Does Endo Pharmaceuticals sponsor H-1B visas?
- Yes. Endo Pharmaceuticals has filed 2 certified H-1B Labor Condition Applications (LCAs) over FY2020–FY2021. An LCA is a required step before an employer files an H-1B petition; a certified LCA does not by itself guarantee an approved visa.
- What is the median H-1B salary at Endo Pharmaceuticals?
- In FY2021, the median certified H-1B base salary at Endo Pharmaceuticals was $273k, with a 25th–75th percentile range of $273k–$273k. This is the annual base wage stated on the LCA and excludes bonus, equity, and other compensation.
- What jobs does Endo Pharmaceuticals hire H-1B workers for?
- Endo Pharmaceuticals's most-filed H-1B role is It Audit Manager (1 filings). Its top worksite state is NY.
- How many H-1B filings did Endo Pharmaceuticals submit in FY2021?
- Endo Pharmaceuticals had 1 certified H-1B LCA filings in FY2021 — a level reading from the prior fiscal year.